Viewing Study NCT01627327


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-03-07 @ 3:47 PM
Study NCT ID: NCT01627327
Status: COMPLETED
Last Update Posted: 2017-11-09
First Post: 2012-06-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardiovascular event View
None Cardiovascular disease View